Short stature and growth hormone

Indian Journal of Pediatrics

Volumn 72, Issue 2, 2005, Pages 149-157

  Kamboj, Manmohan ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Growth hormone (GH); Idiopathic short stature (ISS); Insulin like growth factor 1 (IGF 1); Short stature; Small for gestational age (SGA)

Indexed keywords

ARGININE; CLONIDINE; ESTROGEN; GLUCAGON; GROWTH HORMONE; INSULIN; LEVODOPA; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SERMORELIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACUTE PANCREATITIS; ADRENAL INSUFFICIENCY; ARTHRALGIA; BODY GROWTH; BODY HEIGHT; BRAIN PSEUDOTUMOR; CANCER; CARBOHYDRATE METABOLISM; CARPAL TUNNEL SYNDROME; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG FATALITY; DRUG SAFETY; EDEMA; EPIPHYSIOLYSIS; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH RATE; GROWTH RETARDATION; HEALTH CARE ACCESS; HUMAN; HYPERGLYCEMIA; HYPOTHYROIDISM; INSULIN RESISTANCE; INTRACRANIAL HYPERTENSION; KYPHOSIS; LEUKEMIA; LIVER DISEASE; METABOLIC DISORDER; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRADER WILLI SYNDROME; PROVOCATION TEST; SCOLIOSIS; SHORT STATURE; SIDE EFFECT; SMALL FOR DATE INFANT; SODIUM RETENTION; TUMOR RECURRENCE; TURNER SYNDROME; WASTING SYNDROME;

EID: 15044359283     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02760701     Document Type: Conference Paper

References (46)

1. th edn. New York, U.S.A. Marcel Dekker 2003; 1-46.
2. Tanner JM, Whitehouse RH. Clinical longitudinal standard for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976; 51: 170-171.
3. Tanner JM, Whitehouse RH, Marshall WA, Carter BS. Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16, with allowance for midparent height. Arch Dis Child 1975; 50: 14-26.
4. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standard. J Pediatr 1952; 40: 423-441.
5. 2 Method). London: Academic Press, 1983.
6. nd edn. Stanford, CA, Stanford University Press, U.S.A. 1959.
7. nd edn. Saunders, U.S.A. 2002.
8. Rosenfeld RG, Albertsson-Wikland K, Cassorla F et al. Diagnostic controversy: The diagnosis of childhood GH deficiency revisited. J Clin Endocrinol Metab 1995; 80(5): 1532-1540.
9. GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85(11): 3990-3993.
10. Maghnie M, Strigazzi C, Tinelli C et al. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 1999; 84(4): 1324-1328.
11. Wilson TA, Rose SR, Cohen P et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003; 143(4): 415-421.
12. MacGillivray MH. The basics for the diagnosis and management of short stature: a pediatric endocrinologist's approach. Pediatr Annals 2000; 29(9): 570-575.
13. Cohen P, Bright GM, Rogol AD et al. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 2002; 87(1): 90-98.
14. Reiter EO, Attie KM, Moshang T Jr et al. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naïve pediatric patients with GH deficiency. J Clin Endocrinol Metab 2001; 86(10): 4700-4706.
15. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P. International Small for Gestational Age Advisory Board. International small for gestational age advisory board consensus development conference statement: Management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 2003; 111(6): 1253-1261.
16. Abuzzahab MJ, Schneider A, Goddard A et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003; 349(23): 2211-2212.
17. de Zegher F, Du Caju MV, Heinrichs C et al. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years. J Clin Endocrinol Metab 1999; 845): 1558-1561.
18. Boguszewski M, Albertsson-Wikland K, Aronsson S et al. Growth hormone treatment of short children born small-for-gestational-age: The Nordic Multicentre Trial. Acta Paediatr 1998; 87(3): 257-263.
19. Ranke MB, Lindberg A, Cowell CT et al. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J Clin Endocrinol Metab 2003; 88(1): 125-131.
20. Kamp GA, Mul D, Waelkens JJ et al. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab 2001; 86(7): 2969-2975.
21. Carel JC, Chatelain P, Rochiccioli P, Chaussain JL. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. Endocrinol Metab 2003; 88(4): 1587-1593.
22. Arends NJ, Boonstra VH, Mulder PG et al. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial. Clin Endocrinol 2003; 59(6): 779-787.
23. Cuttler I, Silver JB. Growth hormone treatment for idiopathic short stature implications for practice and policy. Arch Pediatr Adolesc Med 2004; 158(2): 108-110.
24. Endocrinologic and Metabolic Drugs Advisory Committee. Humatrope for Non-Growth Hormone Deficient Short Stature. Indianapolis, Indiana: Lilly Research Laboratories, U.S.A.; 2003. Briefing Document.
25. Finkelstein B, Imperiale T, Speroff T, Marrero U, Radcliffe DJ, Cuttler L. Effects of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 2002; 156(2): 230-240.
26. Rosenfeld R, Hwa V. Toward a molecular basis for idiopathic short stature. J Clin Endocrinol Metab 89(3): 1066-1067.
27. Wit JM, Rekers-Mombarg LT. Dutch Growth Hormone Advisory Group. Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab 87(2): 604-611.
28. Kamp GA, Mul D, Waelkens JJ et al. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. Endocrinol Metab 2001; 86(7): 2969-2975.
29. Saenger P, Wikland KA, Conway GS et al. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001; 86(7): 3061-3069.
30. Frias JL, Davenport ML. Committee on Genetics and Section on Endocrinology. Health supervision for children with Turner syndrome. Pediatrics 2003; 111(3): 692-702.
31. Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J. Growth hormone therapy of Turner syndrome: the impact on final height Genetech, Inc., Collaborative Study Group. J Clin Endocrinol Metab 2000; 85(7): 2439-2445.
32. Lee PDK, Allen DB, Angulo MA et al. Consensus statement - Prader-Willi Syndrome: growth hormone (GH)/ insulin-like growth factor axis deficiency and GH treatment. The Endocrinologist 10(4): 71-73.
33. Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi Syndrome. J Pediatr Endocrinol Metab 1996; 9(3): 393-400.
34. Davies PS, Evans S, Broomhead S et al. Effect of growth hormone on height, weight and body composition in Prader-Willi Syndrome. Arch Dis Child 1998; 78(5): 474-476.
35. Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab 2002; 87(4): 1581-1585.
36. Warady BA, Jabs K. New hormones in the therapeutic arsenal of chronic renal failure: growth failure and erythropoietin. Pediatr Clin North Am 1995; 42(6): 1551-1577.
37. Rosenfeld R, Allen DB, MacGillivray MH, et al. Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders. Am J Managed Care 2000; 6(15): 805-816.
38. Fine RN. Growth hormone in children with chronic renal insufficiency and end-stage renal disease. The Endocrinologist 1998; 8: 160-169.
39. Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 2000; 343(13): 923-930.
40. Roelfsema V, Clark RG. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol 2001; 12(6): 1297-1306.
41. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998; 83 (2): 379-381.
42. Van Rossum AM, Gaakeer MI, Verweel S et al. Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors. Pediatr Infect Dis J 2003; 22(1): 70-76.
43. Kamboj MK, Axelrod FB, David R et al. Growth hormone treatment in children with familial dysautonomia. J Pediatr 2004; 144(1): 63-67.
44. Shohat M, Tick D, Barakat S, Bu X, Melmed S, Rimoin DL. Short term recombinant growth hormone treatment increases growth rate in achondroplasia. J Clin Endocrinol Metab 1996; 81(11): 4033-4037.
45. Anneren G, Tuvemo T, Carlsson-Skwirut C et al. Growth treatment in young children with Down's syndrome: effects on growth and psychomotor development. Arch Dis Child 1999; 80(4) : 334-338.
46. Hardin DS, Stratton R, Kramer JC, de la Rocha RS, Govaerts K, Wilson DP. Growth hormone improves weight velocity and growth velocity in prepubertal children with cystic fibrosis. Horm Metab Res 1998; 30(10): 636-641.